Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lead Time of the Methotrexate Establishment and Vaccinal Protection Against the Pneumococcal Agent in Patients Affected With Rheumatoid Polyarthritis

NCT01942174 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT01942174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01942174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lead Time of the Methotrexate Establishment and Vaccinal Protection Against the Pneumococcal Agent in Patients Affected With Rheumatoid Polyarthritis
Lead sponsor
University Hospital, Montpellier
Phase
Phase 3
Overall status
Completed
Start date
September 27, 2013
Completion date
July 10, 2019
Enrollment
276 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis